Diagnosis of TB in Belarus, statistics and challenges of establishing an accurate and timely DR-TB diagnosis in high MDR-TB prevalence settings

Size: px
Start display at page:

Download "Diagnosis of TB in Belarus, statistics and challenges of establishing an accurate and timely DR-TB diagnosis in high MDR-TB prevalence settings"

Transcription

1 Tuberculosis in 2017: Searching for new solutions in the face of new challenges 6th TB Symposium Ministry of Health of the Republic of Belarus, Republican Scientific and Practical Center for Pulmonology and Tuberculosis, and Médecins Sans Frontières 1-2 March, 2017, MINSK, BELARUS Diagnosis of TB in Belarus, statistics and challenges of establishing an accurate and timely DR-TB diagnosis in high MDR-TB prevalence settings Elena Nikolenko, National TB laboratory

2 Elena Nikolenko, National TB laboratory (NRL) March 01-02, 2017, Minsk

3 SNRL NRL Laboratories Labaratory Network: 3 BSL laboratories (7) 2 BSL laboratories (19) 1 BSL laboratories (128) TB - Laboratory Network RRL BELARUS

4 Laboratory network (new methods are included) NRL (GX-2) 3 BSL laboratories (GX-8) 2 BSL laboratories (GX-13) 1 BSL laboratories (GX-7) Grodno Minsk Vitebsk Mogilev Gomel Brest RRL BELARUS

5 Doctors Laboratory technicians

6 XpertMTB/Rif 1 st sputum sample Microscopy Culture / drug susceptibility testing on solid and soft media 2nd sputum sample Microscopy Culture / drug susceptibility testing on solid and soft media LPA Microbiological diagnostics of TB

7 AFB+, GX+ RIF - S RIF - R LPA MTBDRplus DST for 1 st line drugs LPA MTBDRsl DST for 1 st and 2 nd line drugs Microbiological diagnostics of TB

8

9 SGM, Isolation Rate (%),

10

11

12 Xpert MTB/RIF Brest Vitebsk Gomel Grodno Minsk Oblast Mogilev Minsk Correctional facility No. 12 NRL

13 Brest Vitebsk Gomel Grodno Minsk Mogilev Correctional facility No. 12 NRL

14

15 This method is called "sputum smear microscopy Sputum culture Sputum culture Final outcome: Final outcome:

16 Microscopy Z-N Culture Löwenstein Jensen Culture MGIT 17 GX GX RIF-R negative result, % positive result, % LPA MTBDRplus RIF-R 36.3 LPA MTBDRsl Ag-R LPA MTBDRsl FQ-R

17 Efficiency of microscopic test carried to analyze the deposit in compliance with Ziehl-Neelsen method, Republic of Belarus (2016) 100% 98% 96% % 92% 90% AFB+ AFB diagnostics treatment 88% 5.0 monitoring 0.0

18

19 DST for diagnostics, 2016 H,R,E,Z Am,Km,Cm, Lfx,Mfx, Lzd 2045 H,R,E, Am,Km,Cm, 2800

20 Insufficient use of molecular tests (LPA & GX) and prolonged waiting for the LPA results Dependence on external supplies and irregularities in supplies Insufficient number of staff members Need to undertake reorganization in some 3 BSL laboratories

21 Increased efficiency and quality of tests, improved quality control of laboratory tuberculosis diagnostics During several last years the country s laboratories have been enrolled in external quality control of DST with excellent results Development of international co-operation

22 OBJECTIVR:50%: New cases OBJECTIVE: 70% Relapses: Objectives: 100% BACTERIOLOGICAL CONFIRMATION OF RESPIRATORY TUBERCULOSIS AMONG PRIMARY TB CASES (MOH, REPUBLIC OF BELARUS) BACTERIOLOGICAL CONFIRMATION OF RESPIRATORY TUBERCULOSIS (MOH, REPUBLIC OF BELARUS)

23 Confirmed TB cases among children in 2016, % Confirmed TB of other organs, 2016 (%) AFB+ Mycobacterium tuberculosis+ 0 Mycobacterium tuberculosis+

24 FIND Expand TB (technical assistance to the NRL and the laboratory of Minsk Oblast TB Dispensary) Expert ULTRA TB-SLMTA National Institutes of Health / National Institute of Allergy and Infection Diseases (NIH/NIAID): complete genomic sequencing

25 1) Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance Abigail L Manson, Keira A Cohen, Thomas Abeel, Christopher A Desjardins, Derek T Armstrong, Clifton E Barry III, Jeannette Brand, TBResist Global Genome Consortium, Sinéad B Chapman, Sang-Nae Cho, Andrei Gabrielian, James Gomez, Andreea M Jodals, Moses Joloba, Pontus Jureen, Jong Seok Lee, Lesibana Malinga, Mamoudou Maiga, Dale Nordenberg, Ecaterina Noroc, Elena Romancenco, Alex Salazar, Willy Ssengooba, A A Velayati, Kathryn Winglee, Aena Skrahina, Sven Hoffner et al. Nature Genetics (2017) doi: /ng.3767, Received 30 June 2016 Accepted 14 December 2016 Published online 16 January ) Whole genome sequencing of Mycobacterium tuberculosis provides insight into the evolution and genetic composition of drug-resistant tuberculosis in Belarus. Wollenberg KR, Desjardins CA, Zalutskaya A, Slodovnikova V, Oler AJ, Quiñones M, Abeel T, Chapman SB, Tartakovsky M, Gabrielian A, Hoffner S, Skrahin A, Birren BW, Rosenthal A, Skrahina A, Earl AM. J Clin Microbiol Nov 30. 3) Multidrug-resistant Myobacterium tuberculosis caused by the Beijing genotype and a specific T1 genotype clone (SIT No. 266) is widely transmitted in Minsk Aksana Zalutskaya, Maria Wijkander, Pontus Jureen, Alena Skrahina, Sven Hoffner Int J of Mycobacteriology 2013; 2:

26

27

28 Introduction of a new diagnostics algorithm Capacity to apply rapid methods and molecular tests (GX and LPA) while diagnosing patients Centralization of the Laboratory Network Conduction of external quality assessment Preparation of the NRL for accreditation Increasing capacities of the NRL to ensure regular conduction of clinical and scientific trials

29 Acknowledgements

Multidrug-Resistant TB

Multidrug-Resistant TB Multidrug-Resistant TB Diagnosis Treatment Linking Diagnosis and Treatment Charles L. Daley, M.D. National Jewish Health University of Colorado Denver Disclosures Chair, Data Monitoring Committee for delamanid

More information

Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance

Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance 27 Nature America, Inc., part of Springer Nature. All rights

More information

The Lancet Infectious Diseases

The Lancet Infectious Diseases Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study Susan E Dorman, Samuel G Schumacher, David Alland et al. 2017

More information

Epidemiology and diagnosis of MDR-TB in children H Simon Schaaf

Epidemiology and diagnosis of MDR-TB in children H Simon Schaaf Epidemiology and diagnosis of MDR-TB in children H Simon Schaaf Desmond Tutu TB Centre Department of Paediatrics and Child Health, Stellenbosch University, and Tygerberg Children s Hospital (TCH) Definitions

More information

TB 101 Disease, Clinical Assessment and Lab Testing

TB 101 Disease, Clinical Assessment and Lab Testing TB 101 Disease, Clinical Assessment and Lab Testing Pacific Islands Tuberculosis Controllers Association Conference (PITCA) Clinical Laboratory Breakout None Disclosure Objectives Be able to list and explain

More information

Comparative performance of emerging rapid diagnostics in HIV-infected individuals

Comparative performance of emerging rapid diagnostics in HIV-infected individuals Comparative performance of emerging rapid diagnostics in HIV-infected individuals Maunank Shah M.D. Johns Hopkins University Clinical Diagnostics Research Consortium Background Emerging diagnostics may

More information

Laboratory Diagnostic Techniques. Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust

Laboratory Diagnostic Techniques. Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust Laboratory Diagnostic Techniques Hugo Donaldson Consultant Microbiologist Imperial College Healthcare NHS Trust Learning Objectives 1) When to consider a diagnosis of TB 2) When to consider a referral

More information

DST for detection of DR TB - roll out of Xpert in South Africa and overview of other technologies: what are the gaps?

DST for detection of DR TB - roll out of Xpert in South Africa and overview of other technologies: what are the gaps? DST for detection of DR TB - roll out of Xpert in South Africa and overview of other technologies: what are the gaps? Mark Nicol Division of Medical Microbiology and Institute for Infectious Diseases and

More information

Evaluation of the Microscopic-Observation. Drug-Susceptibility Assay Drugs Concentration for Detection Of Multidrug-Resistant Tuberculosis

Evaluation of the Microscopic-Observation. Drug-Susceptibility Assay Drugs Concentration for Detection Of Multidrug-Resistant Tuberculosis Evaluation of the Microscopic-Observation Drug-Susceptibility Assay Drugs Concentration for Detection Of Multidrug-Resistant Tuberculosis ABSTRACT New diagnostic tools are urgently needed to interrupt

More information

Results from the endtb Project in Kazakhstan

Results from the endtb Project in Kazakhstan Tuberculosis in 2017: Searching for new solutions in the face of new challenges 6th TB Symposium Ministry of Health of the Republic of Belarus, Republican Scientific and Practical Center for Pulmonology

More information

Short MDR-TB Regimen, Uzbekistan

Short MDR-TB Regimen, Uzbekistan Tuberculosis in 2017: Searching for new solutions in the face of new challenges 6th TB Symposium Ministry of Health of the Republic of Belarus, Republican Scientific and Practical Center for Pulmonology

More information

Assessing the programmatic management of drug-resistant TB

Assessing the programmatic management of drug-resistant TB Assessing the programmatic management of drug-resistant TB a. Review the programmatic management of drug-resistant TB patients with the TB manager. i. What is the size of MDR-TB problem locally? How many

More information

AMR SURVEILLANCE IN THE REPUBLIC OF BELARUS

AMR SURVEILLANCE IN THE REPUBLIC OF BELARUS MINISTRY OF HEALTH OF THE REPUBLIC OF BELARUS THE REPUBLICAN RESEARCH AND PRACTICAL CENTER FOR EPIDEMIOLOGY AND MICROBIOLOGY AMR SURVEILLANCE IN THE REPUBLIC OF BELARUS Leonid P. Titov Associate Member

More information

World Journal of Pharmaceutical and Life Sciences WJPLS

World Journal of Pharmaceutical and Life Sciences WJPLS wjpls, 2019, Vol. 5, Issue 2, 01-06 Research Article ISSN 2454-2229 WJPLS www.wjpls.org SJIF Impact Factor: 5.008 COMPARATIVE STUDY BETWEEN GENEXPERT MTB/RIF ASSAY AND DIRECT SMEAR MICROSCOPY(DSM) FOR

More information

Xpert MTB/RIF assay validation experience --- impact and plan in China

Xpert MTB/RIF assay validation experience --- impact and plan in China Xpert MTB/RIF assay validation experience --- impact and plan in China Dr. Zhao Yanlin Chinese Center for Disease Control & Prevention Dr. Richard O Brien FIND April. 16, 2013 Progress Contribution for

More information

Progress Report March 2016

Progress Report March 2016 Progress Report March 2016 Table of Contents Background to project 3 Assays performed to date 3 Correctional Services 5 Peri-Mining 6 Rif Concordance 7 Training: Laboratory and Clinical 7 Challenges identified

More information

New frontiers: Innovation and Access

New frontiers: Innovation and Access 8th Regional TB Symposium Tashkent, Uzbekistan Prof. L.N. Chernousova Central Tuberculosis Research Institute (CTRI) Ministry of Health of the Republic of Uzbekistan 28 February 1 March, 2019 1970 1975

More information

HIV Clinicians Society Conference TB/HIV Treatment Cascade

HIV Clinicians Society Conference TB/HIV Treatment Cascade HIV Clinicians Society Conference-2012 TB/HIV Treatment Cascade Dr Judith Mwansa-Kambafwile Wits Reproductive Health & HIV Institute University of Witwatersrand TB/HIV Treatment Cascade Overview TB stats

More information

Laboratory diagnosis of TB in Bulgaria. Elizabeta Bachiyska, TB NRL, NCIPD

Laboratory diagnosis of TB in Bulgaria. Elizabeta Bachiyska, TB NRL, NCIPD Laboratory diagnosis of TB in Bulgaria Elizabeta Bachiyska, TB NRL, NCIPD Country profile Location: South East Europe, Balkan peninsula Area: 110 993,6 m 2 Population * : 7 284 552 inhabitants Capital

More information

National Xpert MTB/RIF Programme

National Xpert MTB/RIF Programme National Xpert MTB/RIF Programme 1. Background to Project This project was initiated at the request of the Honorable Minister of Health, Dr Aaron Motsoaledi, in early 2011, following the World Health Organization

More information

TB/HIV 2 sides of the same coin. Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai

TB/HIV 2 sides of the same coin. Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai TB/HIV 2 sides of the same coin Dr. Shamma Shetye, MD Microbiology Metropolis Healthcare, Mumbai Global- Tb new cases Diagnosis-Microscopy ZN,Flourescent microscopy(fm) Rapid, inexpensive test Specificity>95%

More information

Bedaquiline and delamanid Experience of use in children. Bobojon Sharipov Deputy Director of the Republican Tuberculosis Control Centre

Bedaquiline and delamanid Experience of use in children. Bobojon Sharipov Deputy Director of the Republican Tuberculosis Control Centre Tuberculosis in 2017: Searching for new solutions in the face of new challenges 6th TB Symposium Ministry of Health of the Republic of Belarus, Republican Scientific and Practical Center for Pulmonology

More information

How best to structure a laboratory network with new technologies

How best to structure a laboratory network with new technologies How best to structure a laboratory network with new technologies Cristina Gutierrez, MD, PhD Uniting to scale up TB care in Central Asia 14 and 15 April 2011 Tashkent, Uzbekistan New laboratory diagnostics

More information

Soedarsono Department of Pulmonology & Respiratory Medicine Faculty of Medicine, Universitas Airlangga Dr. Soetomo General Hospital

Soedarsono Department of Pulmonology & Respiratory Medicine Faculty of Medicine, Universitas Airlangga Dr. Soetomo General Hospital Soedarsono Department of Pulmonology & Respiratory Medicine Faculty of Medicine, Universitas Airlangga Dr. Soetomo General Hospital There were an estimated 10.4 million new TB cases in 2015, higher than

More information

Detection of Multidrug Resistance and Characterization of Mutations in Mycobacterium tuberculosis Isolates in Raichur District, India

Detection of Multidrug Resistance and Characterization of Mutations in Mycobacterium tuberculosis Isolates in Raichur District, India International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 10 (2017) pp. 1543-1549 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.610.185

More information

Detection of heteroresistant Mycobacterium tuberculosis by pyrosequencing

Detection of heteroresistant Mycobacterium tuberculosis by pyrosequencing JCM Accepts, published online ahead of print on 18 September 2013 J. Clin. Microbiol. doi:10.1128/jcm.01761-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 Detection of heteroresistant

More information

Xpert MTB/Rif What place for TB diagnosis in MSF projects? Francis Varaine, MSF Geneva, 29/11/10

Xpert MTB/Rif What place for TB diagnosis in MSF projects? Francis Varaine, MSF Geneva, 29/11/10 Xpert MTB/Rif What place for TB diagnosis in MSF projects? Francis Varaine, MSF Geneva, 29/11/10 Introduction Excellent performances, rapid results, and easy to use Questions Where and how are we going

More information

Green Light Committee for the WHO European Region

Green Light Committee for the WHO European Region Green Light Committee for the WHO European Region Country support mission report Ukraine 17 21 September 2018 Country: Ukraine Dates: 17 21 September 2018 Consultants: Content editors: Language editor:

More information

Online Annexes (2-4)

Online Annexes (2-4) Online Annexes (2-4) to WHO Policy update: The use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin THE END TB STRATEGY Online Annexes (2-4) to WHO Policy update:

More information

Principles of laboratory diagnosis of M. tuberculosis. Anne-Marie Demers, MD, FRCPC 11 September 2017

Principles of laboratory diagnosis of M. tuberculosis. Anne-Marie Demers, MD, FRCPC 11 September 2017 Principles of laboratory diagnosis of M. tuberculosis Anne-Marie Demers, MD, FRCPC 11 September 2017 QUESTION Which statement is false? 1) A smear can only be on a concentrated specimen 2) It is normal

More information

Research Methods for TB Diagnostics. Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012

Research Methods for TB Diagnostics. Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012 Research Methods for TB Diagnostics Kathy DeRiemer, PhD, MPH University of California, Davis Shanghai, China: May 8, 2012 Overview Why do we need good TB diagnostics? What works? What doesn t work? How

More information

Overview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing

Overview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing Overview of Mycobacterial Culture, Identification, and Drug Susceptibility Testing 1. Essentials for the Mycobacteriology Laboratory: Promoting Quality Practices 1.1 Overview: Mycobacterial Culture, Identification,

More information

572 Biomed Environ Sci, 2018; 31(8):

572 Biomed Environ Sci, 2018; 31(8): 572 Biomed Environ Sci, 2018; 31(8): 572-578 Original Article Evaluation of the New Automatic Mycob.T Stainer and Scanner for Detecting Acid-fast Bacilli in China * LI Qiang 1, ZHAO Yan Lin 2,#, WANG Qing

More information

Drug resistance surveillance: progress to date and emerging innovations

Drug resistance surveillance: progress to date and emerging innovations Drug resistance surveillance: progress to date and emerging innovations Anna Dean Matteo Zignol WHO Global Task Force on TB Impact Measurement Glion-sur-Montreux 19 21 April 2016 1. Global project on anti-tb

More information

BMC Infectious Diseases

BMC Infectious Diseases BMC Infectious Diseases This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. Rapid screening of

More information

Drug susceptibility testing for tuberculosis KRISTEN DICKS, MD, MPH DUKE UNIVERSITY MEDICAL CENTER

Drug susceptibility testing for tuberculosis KRISTEN DICKS, MD, MPH DUKE UNIVERSITY MEDICAL CENTER Drug susceptibility testing for tuberculosis KRISTEN DICKS, MD, MPH DUKE UNIVERSITY MEDICAL CENTER Outline Drug resistant TB: definitions and epidemiology How does TB become resistant? Current drug susceptibility

More information

CDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California

CDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California CDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California These guidelines are intended to be used as an educational aid to help clinicians make informed decisions about patient

More information

Ken Jost, BA, has the following disclosures to make:

Ken Jost, BA, has the following disclosures to make: Diagnosis of TB Disease: Laboratory Ken Jost, BA May 10, 2017 TB Intensive May 9-12, 2017 San Antonio, TX EXCELLENCE EXPERTISE INNOVATION Ken Jost, BA, has the following disclosures to make: No conflict

More information

New and repurposed anti-tb drug introduction and active TB drug-safety monitoring and management

New and repurposed anti-tb drug introduction and active TB drug-safety monitoring and management New and repurposed anti-tb drug introduction and active TB drug-safety monitoring and management Alena Skrahina, NTP Belarus WOLFHEZE WORKSHOPS 2017 REACHING OUT To find, treat and cure more TB patients

More information

Frances Morgan, PhD October 21, Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS

Frances Morgan, PhD October 21, Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS The Laboratory s Role in Caring for Patients Diagnosed with TB Frances Morgan, PhD October 21, 2015 Comprehensive Care of Patients with Tuberculosis and Their Contacts October 19 22, 2015 Wichita, KS EXCELLENCE

More information

Online Annexes (5-8)

Online Annexes (5-8) 2016 Online Annexes (5-8) to WHO Policy guidance: The use of molecular line probe assay for the detection of resistance to second-line anti-tuberculosis drugs 1 Contents: Annex 5: GRADE summary of findings

More information

Alcohol addiction in Belarus. Harm reduction programme

Alcohol addiction in Belarus. Harm reduction programme Tuberculosis in 2017: Searching for new solutions in the face of new challenges 6th TB Symposium Ministry of Health of the Republic of Belarus, Republican Scientific and Practical Center for Pulmonology

More information

Xpert MTB/RIF Training. Indira Soundiram 2012

Xpert MTB/RIF Training. Indira Soundiram 2012 Xpert MTB/RIF Training Indira Soundiram 2012 A Better Way to Platform Design GeneXpert Infinity-48 GeneXpert Module GX-I GX-II GX-IV GX-XVI 2 Defining Molecular Diagnostics Any Test Any Time Any Sample

More information

New Frontiers: Innovation and Access

New Frontiers: Innovation and Access 8 th Regional TB Symposium - Tashkent, Uzbekistan New Frontiers: Innovation and Access New Guidelines: An Opportunity for National Programmes and Patients: Evidence for new WHO recommendations on MDR-TB

More information

A retrospective evaluation study of diagnostic accuracy of Xpert MTB/RIF assay, used for detection of Mycobacterium tuberculosis in Greece

A retrospective evaluation study of diagnostic accuracy of Xpert MTB/RIF assay, used for detection of Mycobacterium tuberculosis in Greece Örebro University School of Health and Medical Science Biomedical Laboratory Science Programme 180 credits Degree project in biomedical laboratory science, advanced course, 15 credits May 21, 2015 A retrospective

More information

Online Annexes (5-8)

Online Annexes (5-8) Online Annexes (5-8) to WHO Policy guidance: The use of molecular line probe assay for the detection of resistance to second-line anti-tuberculosis drugs THE END TB STRATEGY Online Annexes (5-8) to WHO

More information

Roll-out of new TB drugs and short-course regimens in the Kyrgyz Republic

Roll-out of new TB drugs and short-course regimens in the Kyrgyz Republic Treating Patient, Not Disease: People-Centered Approach 1-2 March, 2018, BISHKEK, KYRGYZSTAN Roll-out of new TB drugs and short-course regimens in the Kyrgyz Republic A. Kadyrov, PhD in Medicine Director

More information

TB FIT Modelling. 24th Annual PhilCAT Convention. Ivor Langley and Ewan Tomeny Liverpool School of Tropical Medicine AUGUST 2017

TB FIT Modelling. 24th Annual PhilCAT Convention. Ivor Langley and Ewan Tomeny Liverpool School of Tropical Medicine AUGUST 2017 TB FIT Modelling 24th Annual PhilCAT Convention Ivor Langley and Ewan Tomeny Liverpool School of Tropical Medicine AUGUST 2017 TB-FIT - Objectives 1. Develop a computer model of patient pathways for diagnosis

More information

Diagnosis of TB: Laboratory Ken Jost Tuesday April 9, 2013

Diagnosis of TB: Laboratory Ken Jost Tuesday April 9, 2013 TB Nurse Case Management San Antonio, Texas April 9-11, 2013 Diagnosis of TB: Laboratory Ken Jost Tuesday April 9, 2013 Ken Jost has the following disclosures to make: No conflict of interests No relevant

More information

Shah: Discordant Growth- Molecular Rifampin Resistance 2/27/16 RELAPSED FAILED

Shah: Discordant Growth- Molecular Rifampin Resistance 2/27/16 RELAPSED FAILED /7/6 Discordant Growth- Molecular Diagnos7c Challenges and Treatment Outcomes Neha Shah, MD MPH Centers for Disease Control and Preven7on California Department of Health Tuberculosis Control NAR February

More information

MIC = Many Inherent Challenges Sensititre MIC for Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis complex

MIC = Many Inherent Challenges Sensititre MIC for Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis complex MIC = Many Inherent Challenges Sensititre MIC for Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis complex Marie Claire Rowlinson, PhD D(ABMM) Florida Bureau of Public Health Laboratories

More information

MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT

MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives Martie van der Walt IOM Meeting 15-17 January 2013 introduction 1 min 150 words

More information

GLI model TB diagnostic algorithms

GLI model TB diagnostic algorithms GLI model TB diagnostic algorithms GLI model TB diagnostic algorithms Revised June 2018 Contents Acknowledgements Abbreviations v vi Background 1 Algorithm 1: Preferred algorithm for universal patient

More information

Laboratory Diagnosis for MDR TB

Laboratory Diagnosis for MDR TB Laboratory Diagnosis for MDR TB Neha Shah MD MPH Centers for Disease Control and Prevention Division of Tuberculosis Elimination California Department of Public Health Guam March 07 Objectives Describe

More information

Elizabeth A. Talbot MD Assoc Professor, ID and Int l Health Deputy State Epidemiologist, NH GEISELMED.DARTMOUTH.EDU GEISELMED.DARTMOUTH.

Elizabeth A. Talbot MD Assoc Professor, ID and Int l Health Deputy State Epidemiologist, NH GEISELMED.DARTMOUTH.EDU GEISELMED.DARTMOUTH. The image part with relationship ID rid2 was not found in the file. MDR TB Management Review of the Evolution (or Revolution?) Elizabeth A. Talbot MD Assoc Professor, ID and Int l Health Deputy State Epidemiologist,

More information

Diagnosis of Tuberculosis by GeneXpert MTB/RIF Assay Technology: A Short Review

Diagnosis of Tuberculosis by GeneXpert MTB/RIF Assay Technology: A Short Review International Journal of Advanced Microbiology and Health Research www.ijamhr.com Volume 1; Issue 1; September 2017; Page No. 20-24 Review Article Diagnosis of Tuberculosis by GeneXpert MTB/RIF Assay Technology:

More information

TB infection control: overview and importance

TB infection control: overview and importance TB infection control: overview and importance John Ferguson, Newcastle, NSW Infectious Diseases & Microbiology jferguson@hnehealth.nsw.gov.au Goroka Hospital, September 2014 Patterns of TB disease Latent

More information

OUT OF STEP DEADLY IMPLEMENTATION GAPS IN THE TB RESPONSE. A survey of TB diagnostic and treatment practices in eight countries.

OUT OF STEP DEADLY IMPLEMENTATION GAPS IN THE TB RESPONSE. A survey of TB diagnostic and treatment practices in eight countries. OUT OF STEP DEADLY IMPLEMENTATION GAPS IN THE TB RESPONSE A survey of TB diagnostic and treatment practices in eight countries October 2014 www.msfaccess.org ABOUT MÉDECINS SANS FRONTIÈRES (MSF) MSF is

More information

Diagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014

Diagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014 TB Nurse Case Management San Antonio, Texas April 1 3, 2014 Diagnosis of TB: Laboratory Ken Jost Tuesday April 1, 2014 Ken Jost, BA has the following disclosures to make: No conflict of interests No relevant

More information

Clinical and Public Health Impact of Nucleic Acid Amplification Tests (NAATs) for Tuberculosis

Clinical and Public Health Impact of Nucleic Acid Amplification Tests (NAATs) for Tuberculosis Clinical and Public Health Impact of Nucleic Acid Amplification Tests (NAATs) for Tuberculosis Amit S. Chitnis, MD, MPH; Pennan M. Barry, MD, MPH; Jennifer M. Flood, MD, MPH. California Tuberculosis Controllers

More information

GLI model TB diagnostic algorithms

GLI model TB diagnostic algorithms GLI model TB diagnostic algorithms GLI model TB diagnostic algorithms March 2017 Contents Acknowledgements Abbreviations v vi Background 1 Algorithm 1: Preferred algorithm for universal patient access

More information

Health Care Worker Training on Roll Out New TB Diagnostic Test. Prepared by: City Health (J Caldwell) & NHLS (M Bosman & I Noordien)

Health Care Worker Training on Roll Out New TB Diagnostic Test. Prepared by: City Health (J Caldwell) & NHLS (M Bosman & I Noordien) Health Care Worker Training on Roll Out New TB Diagnostic Test Prepared by: City Health (J Caldwell) & NHLS (M Bosman & I Noordien) Overview Specimen Collection Investigations to request Sorting & registering

More information

Diagnosis of tuberculosis in children

Diagnosis of tuberculosis in children Diagnosis of tuberculosis in children H Simon Schaaf Desmond Tutu TB Centre Department of Paediatrics and Child Health, Stellenbosch University, and Tygerberg Children s Hospital (TCH) Estimated TB incidence

More information

Tuberculosis Reference Laboratory, NIDCH, Mahakhali, Dhaka.

Tuberculosis Reference Laboratory, NIDCH, Mahakhali, Dhaka. Bangladesh J Med Microbiol 2011; 05 (02): 06-10 Bangladesh Society of Medical Microbiologists Original Article A rapid Drug Susceptibility Test (DST) for detection of Multi-Drug Resistant (MDR) Mycobacterium

More information

Management of MDR TB. Dr Priscilla Rupali MD; DTM&H Professor and Head Department of Infectious Diseases Christian Medical College Vellore

Management of MDR TB. Dr Priscilla Rupali MD; DTM&H Professor and Head Department of Infectious Diseases Christian Medical College Vellore Management of MDR TB Dr Priscilla Rupali MD; DTM&H Professor and Head Department of Infectious Diseases Christian Medical College Vellore Outline Global epidemiology of Tuberculosis Epidemiology of Tuberculosis

More information

Evaluation of Genxpert Real Time PCR POC in the Diagnosis of Multidrug Resistant TB Among Patients Attending NTBLTC Saye-Zaria Nigeria

Evaluation of Genxpert Real Time PCR POC in the Diagnosis of Multidrug Resistant TB Among Patients Attending NTBLTC Saye-Zaria Nigeria RESEARCH ARTICLE Open Access Journal of Infectious Diseases and Pathogenesis ISSN 577-7939 Evaluation of Genxpert Real Time PCR POC in the Diagnosis of Multidrug Resistant TB Among Patients Attending NTBLTC

More information

Diagnosing Xpert MTB/RIF negative TB suspects: Impact and cost of an alternative algorithm

Diagnosing Xpert MTB/RIF negative TB suspects: Impact and cost of an alternative algorithm Diagnosing Xpert MTB/RIF negative TB suspects: Impact and cost of an alternative algorithm Kathryn Schnippel 1, Gesine Meyer-Rath 1,2, Lawrence Long 1, Wendy Stevens 3,4, Ian Sanne 1,2, and Sydney Rosen

More information

PCR and direct amplification for tuberculosis diagnosis. Emmanuelle CAMBAU University Paris Diderot, APHP, Saint Louis-Lariboisière Hospital,

PCR and direct amplification for tuberculosis diagnosis. Emmanuelle CAMBAU University Paris Diderot, APHP, Saint Louis-Lariboisière Hospital, PCR and direct amplification for tuberculosis diagnosis Emmanuelle CAMBAU University Paris Diderot, APHP, Saint Louis-Lariboisière Hospital, Paris, France Educational Workshop 05- ECCMID 2015 Copenhagen

More information

POSITIONING OF TB DX : TIERED SYSTEM, INTEGRATED APPROACH

POSITIONING OF TB DX : TIERED SYSTEM, INTEGRATED APPROACH POSITIONING OF TB DX : TIERED SYSTEM, INTEGRATED APPROACH Akos Somoskövi, M.D., Ph.D. and Giorgio Roscigno, M.D. ANNUAL GLI MEETING, 4 th OCTOBER 2010 MERIEUX FOUNDATION, ANNECY Integrated Laboratory Network

More information

Treating Patients, Not Disease: People-Centered Approach

Treating Patients, Not Disease: People-Centered Approach Treating Patients, Not Disease: People-Centered Approach 7th Annual TB Symposium Ministry of Health of the Kyrgyz Republic and Médecins Sans Frontières 1-2 March, 2018, BISHKEK, KYRGYZSTAN TB Diagnostics

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Dorman S E, Schumacher S G, Alland D, et al.

More information

Diagnosis of Pulmonary Tuberculosis Using Conventional Smear Microscopy and Culture Methods in a Tertiary Care Hospital

Diagnosis of Pulmonary Tuberculosis Using Conventional Smear Microscopy and Culture Methods in a Tertiary Care Hospital Diagnosis of Pulmonary Tuberculosis Using Conventional Smear Microscopy and Culture Methods in a Tertiary Care Hospital 1 SM.Nachammai, 2 Dr.Mangayarkarasi.V (MD) Abstract: Tuberculosis, one of the oldest

More information

White Paper Application

White Paper Application White Paper Application Project Title: Whole genome sequencing of clinical strains of Mycobacterium tuberculosis Authors: David Alland, Jerrold Ellner, Susan Dorman, Moses Joloba, Clifton Barry Primary

More information

Received 4 June 2013; Final revision 1 August 2013; Accepted 30 August 2013; first published online 27 September 2013

Received 4 June 2013; Final revision 1 August 2013; Accepted 30 August 2013; first published online 27 September 2013 Epidemiol. Infect. (2014), 142, 1328 1333. Cambridge University Press 2013 doi:10.1017/s0950268813002409 SHORT REPORT Characterization of multi-drug resistant Mycobacterium tuberculosis from immigrants

More information

General Session IV - Dale Schwab April 20, 2017

General Session IV - Dale Schwab April 20, 2017 The Culture of Clinical Commercial Labs Presented by: Dale Schwab PhD, Senior Scientific Director, Infectious Disease April 20, 2017 Objectives Challenges for the reference laboratory in MTB diagnosis/opportunities

More information

National Survey of Drug-Resistant Tuberculosis in China Dr. Yanlin Zhao

National Survey of Drug-Resistant Tuberculosis in China Dr. Yanlin Zhao National Survey of Drug-Resistant Tuberculosis in China Dr. Yanlin Zhao National Centre for Tuberculosis Control and Prevention of China CDC National TB Reference Laboratory, China CDC BACKGROUND China

More information

Molecular Methods in the Diagnosis of Drug Resistant Tuberculosis. Dr Sahajal Dhooria

Molecular Methods in the Diagnosis of Drug Resistant Tuberculosis. Dr Sahajal Dhooria Molecular Methods in the Diagnosis of Drug Resistant Tuberculosis Dr Sahajal Dhooria What is drug resistant TB? Definitions MDR TB defined as resistance to isoniazid and rifampicin, with or without resistance

More information

Research Article Factors Associated with Missed Detection of Mycobacterium tuberculosis by Automated BACTEC MGIT 960 System

Research Article Factors Associated with Missed Detection of Mycobacterium tuberculosis by Automated BACTEC MGIT 960 System BioMed Research International Volume 2016, Article ID 5972021, 4 pages http://dx.doi.org/10.1155/2016/5972021 Research Article Factors Associated with Missed Detection of Mycobacterium tuberculosis by

More information

Implementation of Xpert MTB/RIF : Experience of Republic of Moldova

Implementation of Xpert MTB/RIF : Experience of Republic of Moldova Implementation of Xpert MTB/RIF : Experience of Republic of Moldova Domente Liliana Institute of Phthisiopneumology Chiril Draganiuc Antalia, Turkey December 10-13, 2013 TB Epidemic Breakdown Indicator

More information

Mycobacteria & Tuberculosis PROF.HANAN HABIB & PROF ALI SOMILY DEPRTMENT OF PATHOLOGY, MICROBIOLOGY UNIT COLLEGE OF MEDICINE

Mycobacteria & Tuberculosis PROF.HANAN HABIB & PROF ALI SOMILY DEPRTMENT OF PATHOLOGY, MICROBIOLOGY UNIT COLLEGE OF MEDICINE Mycobacteria & Tuberculosis PROF.HANAN HABIB & PROF ALI SOMILY DEPRTMENT OF PATHOLOGY, MICROBIOLOGY UNIT COLLEGE OF MEDICINE Objectives l Recognize that tuberculosis as a chronic disease mainly affecting

More information

SMEAR MICROSCOPY AS SURROGATE FOR CULTURE DURING FOLLOW UP OF PULMONARY MDR-TB PATIENTS ON DOTS PLUS TREATMENT

SMEAR MICROSCOPY AS SURROGATE FOR CULTURE DURING FOLLOW UP OF PULMONARY MDR-TB PATIENTS ON DOTS PLUS TREATMENT Original Article SMEAR MICROSCOPY AS SURROGATE FOR CULTURE DURING FOLLOW UP OF PULMONARY MDR-TB PATIENTS ON DOTS PLUS TREATMENT R. Sarin 1, R. Singla 2, P. Visalakshi 3, A. Jaiswal 4, M.M. Puri 4, Khalid

More information

Recognizing MDR-TB in Children. Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention February 2016

Recognizing MDR-TB in Children. Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention February 2016 Recognizing MDR-TB in Children Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention 17-18 February 2016 Objectives Review the definitions and categorization of drugresistant tuberculosis Understand the

More information

Implementation and scale-up of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB. Global Consultation

Implementation and scale-up of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB. Global Consultation Implementation and scale-up of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB Global Consultation Geneva, 30 November 2010 Mario C. Raviglione, M.D. Director, Stop TB Department WHO, Geneva,

More information

<<Insert Laboratory Logo if applicable>> LABORATORY MANUAL MYCOBACTERIOLOGY CLINICAL SITE

<<Insert Laboratory Logo if applicable>> LABORATORY MANUAL MYCOBACTERIOLOGY CLINICAL SITE LABORATORY MANUAL MYCOBACTERIOLOGY CLINICAL SITE Protocol Title: A Phase 3, Open-Label Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability

More information

The MODS Assay for Detection of TB and TB Drug Resistance: A Multi-center Study

The MODS Assay for Detection of TB and TB Drug Resistance: A Multi-center Study The MODS Assay for Detection of TB and TB Drug Resistance: A Multi-center Study microscopic observation drug susceptibility Susan E. Dorman, MD Johns Hopkins University Afranio L. Kritski, MD, PhD Federal

More information

AN EVALUATION OF CURRENT DIAGNOSTIC METHODS FOR TUBERCLOSIS IN RESOURCE-POOR AREAS AND A PROPOSAL FOR A MORE SENSITIVE TEST. Helen Marya McGuirk

AN EVALUATION OF CURRENT DIAGNOSTIC METHODS FOR TUBERCLOSIS IN RESOURCE-POOR AREAS AND A PROPOSAL FOR A MORE SENSITIVE TEST. Helen Marya McGuirk AN EVALUATION OF CURRENT DIAGNOSTIC METHODS FOR TUBERCLOSIS IN RESOURCE-POOR AREAS AND A PROPOSAL FOR A MORE SENSITIVE TEST by Helen Marya McGuirk B.S., Microbiology, University of Georgia, 2007 Submitted

More information

Clinical Diagnostics Research Consortium (CDRC)

Clinical Diagnostics Research Consortium (CDRC) Clinical Diagnostics Research Consortium (CDRC) Funded through a contract from U.S. National Institute of Allergy and Infectious Disease, National Institutes of Health Mission: to evaluate novel TB diagnostics

More information

Definitions and reporting framework for tuberculosis 2013 revision. Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013

Definitions and reporting framework for tuberculosis 2013 revision. Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013 Definitions and reporting framework for tuberculosis 2013 revision Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013 2-year revision process WHO/HTM/TB/2013.2 2 www.who.int/iris/bitstream/10665/79199/1/9789241505345_eng.pdf

More information

TB Laboratory for Nurses

TB Laboratory for Nurses TB Laboratory for Nurses Shea Rabley, RN, MN Consultant Mayo Clinic Center for Tuberculosis 2014 MFMER slide-1 Disclosures None 2014 MFMER slide-2 Objectives Participants will be able to: 1. Name 2 safety

More information

Republican Research and Practical Center for Radiation Medicine and Human Ecology. Ilya Veyalkin Head of Laboratory of Epidemiology Gomel, Belarus

Republican Research and Practical Center for Radiation Medicine and Human Ecology. Ilya Veyalkin Head of Laboratory of Epidemiology Gomel, Belarus Republican Research and Practical Center for Radiation Medicine and Human Ecology Ilya Veyalkin Head of Laboratory of Epidemiology Gomel, Belarus The contaminated area in the Republic of Belarus consisted

More information

Tuberculosis in Greece: bacteriologically confirmed cases and anti-tuberculosis drug resistance,

Tuberculosis in Greece: bacteriologically confirmed cases and anti-tuberculosis drug resistance, Surveillance and outbreak reports Tuberculosis in Greece: bacteriologically confirmed cases and anti-tuberculosis drug resistance, 1995-2009 D Papaventsis (dpapaventsis@yahoo.gr) 1, S Nikolaou 1, S Karabela

More information

Screening in Maternity to Ascertain Tuberculosis Status (SMATS) study

Screening in Maternity to Ascertain Tuberculosis Status (SMATS) study Broughton et al. BMC Infectious Diseases (2017) 17:191 DOI 10.1186/s12879-017-2285-0 STUDY PROTOCOL Screening in Maternity to Ascertain Tuberculosis Status (SMATS) study Open Access Edward Broughton 1*,

More information

Effectiveness of the WHO regimen for treatment of multidrug resistant tuberculosis (MDR-TB)

Effectiveness of the WHO regimen for treatment of multidrug resistant tuberculosis (MDR-TB) Effectiveness of the WHO regimen for treatment of multidrug resistant tuberculosis (MDR-TB) M Bonnet, M Bastard, P du Cros, K Atadjan, K Kimenye, S Khurkhumal, A Hayrapetyan, A Telnov, C Hewison, F Varaine

More information

CULTURE OR PCR WHAT IS

CULTURE OR PCR WHAT IS CULTURE OR PCR WHAT IS BEST FOR AFRICA? Peter R Mason BRTI TB IN AFRICA GLOBAL 9 MILLION NEW CASES/YR 1.5 MILLION TB DEATHS AFRICA 95% TB DEATHS IN LMIC 9/22 HIGH BURDEN COUNTRIES IN AFRICA STRONG LINK

More information

NAAT in the Clinical Laboratory and Impact on Infection Control 9 th National Conference on Laboratory Aspects of Tuberculosis APHL

NAAT in the Clinical Laboratory and Impact on Infection Control 9 th National Conference on Laboratory Aspects of Tuberculosis APHL NAAT in the Clinical Laboratory and Impact on Infection Control 9 th National Conference on Laboratory Aspects of Tuberculosis APHL Susan Novak-Weekley, S(M), ASCP, Ph.D., D(ABMM) Director of Microbiology,

More information

Introduction. Diagnosis of extrapulmonaryand paediatric tuberculosis. Extrapulmonary tuberculosis EPTB SASCM WORKSHOP 2014/05/24

Introduction. Diagnosis of extrapulmonaryand paediatric tuberculosis. Extrapulmonary tuberculosis EPTB SASCM WORKSHOP 2014/05/24 Diagnosis of extrapulmonaryand paediatric tuberculosis AW Dreyer Centre for Tuberculosis NICD Introduction Part of the global efforts to control tuberculosis (TB) include improving case detection, especially

More information

TB Control in Finland - the role of THL

TB Control in Finland - the role of THL TB Control in Finland - the role of THL Hanna Soini THL, Department of Health Security 1 TB in Finland 1950-2014 12000 10000 8000 6000 TB ulkomaalaiset TB yhteensä 4000 2000 0 1950 1955 1960 1965 1970

More information

Xpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection. Results of Group Work

Xpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection. Results of Group Work Xpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection Results of Group Work DOTS expansion and enhancement Objective This group deals with the majority

More information

Nontuthuko E. Maningi 1*, Lesibana A. Malinga 3, John F. Antiabong 1, Ruth M. Lekalakala 2 and Nontombi M. Mbelle 1,2

Nontuthuko E. Maningi 1*, Lesibana A. Malinga 3, John F. Antiabong 1, Ruth M. Lekalakala 2 and Nontombi M. Mbelle 1,2 Maningi et al. BMC Infectious Diseases (2017) 17:795 DOI 10.1186/s12879-017-2898-3 RESEARCH ARTICLE Open Access Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first

More information

Ministry of Health. National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015)

Ministry of Health. National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015) Ministry of Health National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015) Contents Executive summary... 2 Background... 3 National Tuberculosis Program Overview... 3

More information